RNAi therapeutic and its innovative biotechnological evolution

Y Weng, H ** RES and endosome: challenges for siRNA delivery for cancer therapy
S Guo, L Huang - Journal of Nanomaterials, 2011 - Wiley Online Library
Small interfering RNAs (siRNAs) technology has emerged as a promising potential
treatment for viral, genetic diseases and cancers. Despite the powerful therapeutic potential …

Polymeric modification and its implication in drug delivery: poly-ε-caprolactone (PCL) as a model polymer

TK Dash, VB Konkimalla - Molecular pharmaceutics, 2012 - ACS Publications
Biodegradable polymers provided the opportunity to explore beyond conventional drug
delivery and turned out to be the focus of current drug delivery. In spite of availability of …

Amphiphilic copolymers in biomedical applications: Synthesis routes and property control

F Perin, A Motta, D Maniglio - Materials Science and Engineering: C, 2021 - Elsevier
The request of new materials, matching strict requirements to be applied in precision and
patient-specific medicine, is pushing for the synthesis of more and more complex block …

[HTML][HTML] Poly (ε-caprolactone)-based graft copolymers: synthesis methods and applications in the biomedical field: a review

J Coudane, B Nottelet, J Mouton, X Garric… - Molecules, 2022 - mdpi.com
Synthetic biopolymers are attractive alternatives to biobased polymers, especially because
they rarely induce an immune response in a living organism. Poly ε-caprolactone (PCL) is a …